The sequential ICI arm showed a trend toward improved OS compared with the concurrent ICI arm, although the result was not significant (HR: 0.85 [95% CI 0.72 to 1.00]; Fig. 3 a and Supplementary Fig. 1a).
← all excerpts
Efficacy and safety of sequential versus concurrent administration of immune checkpoint inhibitors with radiotherapy in solid tumors: a systematic review and network meta-analysis.
1
—
—